Yw. Li et al., Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy, CIRCULATION, 101(3), 2000, pp. 231-234
Citations number
14
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-There are still discrepancies in the association of enterovirus
and myocardial disease, partially due to lack of data on the detection of v
irus antigens in tissues. It is desirable to localize enteroviral antigens
so as to establish a link between the two and to study mechanisms of virus
persistence.
Methods and Results-Nineteen fixed explanted or postmortem myocardial sampl
es were obtained from patients with myocarditis or dilated cardiomyopathy (
DCM). Control samples were collected from 11 subjects who had died accident
ally or of noncardiovascular disease. Viral antigen was detected by an impr
oved immunohistochemical technique using an enterovirus group-specific anti
body to viral capsid protein VP1. Nine of 11 myocarditis cases (81.8%) and
6 of 8 DCM cases (75%) were positive. Signals were localized in the cytopla
sm of myocytes. Intense immunostaining was observed in acute myocarditis, w
hereas VP1 was detected in scattered myocytes in chronic myocarditis or DCM
. Enteroviral RNA was detected in 6 of 11 myocarditis samples (54.5%) and 3
of 8 DCM samples (37.5%) by the reverse transcription-nested polymerase ch
ain reaction, correlating with antigen detection (kappa=0.6+/-0.21). Neithe
r viral antigen nor RNA was detected in any controls.
Conclusions-Our findings demonstrate a direct link between enterovirus infe
ction and some myocarditis or DCM cases. The pattern of VP1 detection may c
orrelate with disease stage and severity. The data suggest that viral prote
in synthesis may be involved in persistent enterovirus infection in the pat
hogenesis of DCM.